Abbott Laboratories Investigates Cyber Incidents in Cancer Diagnostics and LabCentral Portal

Abbott Laboratories is probing two cyber incidents involving unauthorized access to its Cancer Diagnostics business and LabCentral portal. The company confirmed that the incidents did not affect operations or other business units. The ShinyHunters extortion group claimed responsibility for the Cancer Diagnostics breach, stating they accessed systems via a vishing attack targeting employees. They threatened to leak over 30 million rows of customer PII unless negotiations occurred. Abbott has engaged cybersecurity experts and law enforcement for investigations and does not expect a material impact on its business or financial results. The LabCentral portal contained only publicly available technical documents, with no sensitive data reported as compromised. The incidents highlight the growing trend of cyberattacks targeting the healthcare sector.

Key Points: • Abbott is investigating two separate cyber incidents involving unauthorized access. • The ShinyHunters group claims to have stolen over 30 million rows of customer PII. • No impact on Abbott's operations or financial results is expected from these incidents.